OTCMKTS:AGTX

Agentix - AGTX Stock Forecast, Price & News

$0.10

0.00 (0.00%)

(As of 03/22/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.10
▼
$0.10
50-Day Range: $0.10
▼
$0.20
52-Week Range: $0.10
▼
$0.36

Volume: 2,000 shs
Average Volume: 2,560 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Agentix

Agentix Corp.is a biotechnology company. The firm is engaged in the development and commercialization of novel therapeutics to treat metabolic diseases, peripheral neuropathy, progressive lung disease and ischemic reperfusion injury. It is focused on the development of synthetic agonists, inverse agonists and antagonists which modulate the endocannabinoid system (ECS). The ECS is a network of G-protein coupled receptors (GPCRs) that help regulate a variety of metabolic and neurotransmission functions. The company was founded on April 18, 2013 and is headquartered in Dana Point, CA.

Receive AGTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agentix and its competitors with MarketBeat's FREE daily newsletter.

AGTX Stock News Headlines

December 20, 2022 | finance.yahoo.com

DelveInsight Estimates a Promising Picture of Obesity Pipeline Space Landscape as Key 100+ Pharma Companies Working in the Space

January 4, 2022 | finanznachrichten.de

Stock Day Media: AGENTIX Discusses 2022 Clinical Development Efforts and Potential Uplisting with The Stock Day Podcast

March 23, 2023 | Health Sector Insight (Ad)

Penny Stock Shows Big Potential

The $4.37 trillion wellness market and the little-known penny stock to get on radar now.

January 4, 2022 | finance.yahoo.com

AGENTIX Discusses 2022 Clinical Development Efforts and Potential Uplisting with The Stock Day Podcast

December 22, 2021 | finanznachrichten.de

AGENTIX Corp.: AGENTIX and RTI International Announce Worldwide Exclusive License and Services Agreement

December 21, 2021 | finance.yahoo.com

AGENTIX and RTI International Announce Worldwide Exclusive License and Services Agreement

September 8, 2021 | finanznachrichten.de

AGENTIX Corp.: AGENTIX Corporation and the National Health Research Institutions Announce Worldwide Exclusive License Agreements

September 8, 2021 | finance.yahoo.com

AGENTIX Corporation and the National Health Research Institutions Announce Worldwide Exclusive License Agreements

March 23, 2023 | Health Sector Insight (Ad)

Penny Stock Shows Big Potential

The $4.37 trillion wellness market and the little-known penny stock to get on radar now.

March 21, 2021 | ca.finance.yahoo.com

Nurcapital Corporation Ltd. and Green Sky Labs Inc. Announce Signing of Definitive Agreement and Provide Update on Proposed Qualifying Transaction

November 11, 2020 | finance.yahoo.com

Agentix Biopharma CEO, Rudy Mazzocchi, Discusses the Company's Growth Strategy with The Stock Day Podcast

October 20, 2020 | finance.yahoo.com

What Kind Of Investors Own Most Of Oil States International, Inc. (NYSE:OIS)?

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive AGTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agentix and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Diversified Industrials
Sub-Industry: N/A
Sector: Industrials
Current Symbol: OTCMKTS:AGTX
CUSIP: N/A
CIK: 1603345
Web: fairwindenergyinc.com
Phone: (321) 299-2014
Fax: N/A
Employees: 147,000
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Rudy A. Mazzocchi
Chairman, President, CEO, CFO & CAO

Martin Schroeder
Chief Scientific Officer

Salman Hoda
Secretary, Treasurer & Director

David Fiene
Controller

Key Competitors

View All Competitors

AGTX Stock - Frequently Asked Questions

How have AGTX shares performed in 2023?: Agentix's stock was trading at $0.1695 at the beginning of the year. Since then, AGTX shares have decreased by 41.0% and is now trading at $0.10.
View the best growth stocks for 2023 here.
What is Agentix's stock symbol?: Agentix trades on the OTCMKTS under the ticker symbol "AGTX."

How do I buy shares of Agentix?: Shares of AGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Agentix's stock price today?: One share of AGTX stock can currently be purchased for approximately $0.10.
How many employees does Agentix have?: The company employs 147,000 workers across the globe.
How can I contact Agentix?: The official website for the company is fairwindenergyinc.com. The company can be reached via phone at (321) 299-2014.

This page (OTCMKTS:AGTX) was last updated on 3/23/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial